Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000003512 | SCV000631429 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2017-08-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with arginine at codon 212 of the SRD5A2 protein (p.Pro212Arg). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and arginine. This variant is present in population databases (rs121434252, ExAC 0.07%). This variant has been reported in many individuals affected with disorders of sex development (PMID: 8110760, 8262007, 9135696, 10718838, 10999800, 20019388) and is suspected to be a founder mutation in the Mexican population (PMID: 20019388). ClinVar contains an entry for this variant (Variation ID: 3348). Experimental studies have shown that this missense change results in loss of enzyme activity (PMID: 8110760, 24665940). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000003512 | SCV000023670 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2000-09-01 | no assertion criteria provided | literature only | |
Clinical Molecular Genetics Laboratory, |
RCV000003512 | SCV000692396 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2010-03-17 | no assertion criteria provided | clinical testing |